Abstract
Stem cell therapy may be a choice therapy for advanced heart failure patients refractory to medical therapy, internal cardiovertor with a defibrillator (ICD) recipients, and a previous history of myocardial infarction and coronary artery revascularization. These patients, without indication to receive a cardiac resynchronization therapy (CRT), may have a worsening of heart failure and symptoms of coronary artery disease. In this study, we have evaluated in consecutive 30 selected patients the amelioration in failing heart NYHA class, hospitalization rate, echocardiographic left ventricle functionality, and associated to reduction of angina after a treatment with stem cell intra-thoracic infusion.
Celestino Sardu, Naples, Italy
Raffaele Marfella, Naples, Italy
ClinicalTrials.gov Identifier: NCT02871466
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Weiss, J.N. (2022). Stem Cell Therapy in Advanced Heart Failure. In: Stem Cell Surgery Trials in Heart Failure and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-78010-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-78010-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78009-8
Online ISBN: 978-3-030-78010-4
eBook Packages: MedicineMedicine (R0)